1-5 of 5
Adelheid Cerwenka
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Sustained effector function of IL-12/15/18–preactivated NK cells against established tumors

Jing Ni, Matthias Miller, Ana Stojanovic, Natalio Garbi, Adelheid Cerwenka
Journal: Journal of Experimental Medicine
J Exp Med (2012) 209 (13): 2351–2365.
https://doi.org/10.1084/jem.20120944
Published: 03 December 2012
View articletitled, Sustained effector function of IL-12/15/18–preactivated NK cells against established tumors
Open the PDF for Sustained effector function of IL-12/15/18–preactivated NK cells against established tumors in another window
Journal Articles

New twist on the regulation of NKG2D ligand expression

Adelheid Cerwenka
Journal: Journal of Experimental Medicine
J Exp Med (2009) 206 (3): 723.
https://doi.org/10.1084/jem.2009022521809c
Published: 02 March 2009
View articletitled, New twist on the regulation of NKG2D ligand expression
Open the PDF for New twist on the regulation of NKG2D ligand expression in another window
Journal Articles

New twist on the regulation of NKG2D ligand expression

Adelheid Cerwenka
Journal: Journal of Experimental Medicine
J Exp Med (2009) 206 (2): 265–268.
https://doi.org/10.1084/jem.20090225
Published: 09 February 2009
View articletitled, New twist on the regulation of NKG2D ligand expression
Open the PDF for New twist on the regulation of NKG2D ligand expression in another window
Journal Articles

Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection

John M. Routes, Sharon Ryan, Kristin Morris, Rayna Takaki, Adelheid Cerwenka, Lewis L. Lanier
Journal: Journal of Experimental Medicine
J Exp Med (2005) 202 (11): 1477–1482.
https://doi.org/10.1084/jem.20050240
Published: 28 November 2005
View articletitled, Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection
Open the PDF for Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection in another window
Includes: Supplementary data
Journal Articles

Migration Kinetics and Final Destination of  Type 1 and Type 2 CD8 Effector Cells Predict Protection against Pulmonary Virus Infection

Adelheid Cerwenka, Tammy M. Morgan, Allen G. Harmsen, Richard W. Dutton
Journal: Journal of Experimental Medicine
J Exp Med (1999) 189 (2): 423–434.
https://doi.org/10.1084/jem.189.2.423
Published: 18 January 1999
View articletitled, Migration Kinetics and Final Destination of  Type 1 and Type 2 CD8 Effector Cells Predict Protection against Pulmonary Virus Infection
Open the PDF for Migration Kinetics and Final Destination of  Type 1 and Type 2 CD8 Effector Cells Predict Protection against Pulmonary Virus Infection in another window